Literature DB >> 7627182

Mutations and polymorphisms in the human ornithine transcarbamylase gene: mutation update addendum.

M Tuchman1, R J Plante.   

Abstract

This mutation update addendum summarizes 30 new mutations and polymorphisms found in the ornithine transcarbamylase (OTC) gene since the publication in this journal of the first mutation update. Thus, more than 60 mutations and polymorphisms in the OTC gene are currently known. Most of the mutations have been seen in a single family and the few recurrent mutations occurred in CpG dinucleotides. The presumed deleterious effects of most mutations await confirmation by appropriate expression studies. Once the tertiary structure of the enzyme is fully known, and the functional domains established, the effects of mutations, or lack thereof, could be better predicted.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627182     DOI: 10.1002/humu.1380050404

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Substrate-induced conformational change in a trimeric ornithine transcarbamoylase.

Authors:  Y Ha; M T McCann; M Tuchman; N M Allewell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Identification of 'private' mutations in patients with ornithine transcarbamylase deficiency.

Authors:  M Tuchman; H Morizono; B S Rajagopal; R J Plante; N M Allewell
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

3.  Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.

Authors:  Jin-Ho Choi; Beom Hee Lee; Ja Hye Kim; Gu-Hwan Kim; Yoo-Mi Kim; Jahyang Cho; Chong-Kun Cheon; Jung Min Ko; Jung Hyun Lee; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2015-09       Impact factor: 3.172

4.  Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families.

Authors:  M Tuchman; R J Plante; M A Garcia-Perez; V Rubio
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

5.  Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces 'late onset' hyperammonaemia.

Authors:  H Morizono; M Tuchman; B S Rajagopal; M T McCann; C D Listrom; X Yuan; D Venugopal; G Barany; N M Allewell
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 6.  Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.

Authors:  Ljubica Caldovic; Iman Abdikarim; Sahas Narain; Mendel Tuchman; Hiroki Morizono
Journal:  J Genet Genomics       Date:  2015-05-19       Impact factor: 4.275

7.  Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.

Authors:  M A García-Pérez; C Climent; P Briones; M A Vilaseca; M Rodés; V Rubio
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

8.  The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

Authors:  M Tuchman; H Morizono; O Reish; X Yuan; N M Allewell
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

9.  Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.

Authors:  J A Arranz; E Riudor; C Marco-Marín; V Rubio
Journal:  J Inherit Metab Dis       Date:  2007-03-01       Impact factor: 4.750

10.  Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.

Authors:  Deyun Lu; Feng Han; Wenjuan Qiu; Huiwen Zhang; Jun Ye; Lili Liang; Yu Wang; Wenjun Ji; Xia Zhan; Xuefan Gu; Lianshu Han
Journal:  Orphanet J Rare Dis       Date:  2020-12-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.